Small is beautiful: How nanotechnology is improving diagnoses of life-threatening illnesses
Women who are diagnosed with breast cancer may soon be helped by a discovery made in 1880 by Alexander Graham Bell.
Currently, the removal of the lymph nodes draining the breast is a routine diagnostic procedure to see whether the cancer has spread. The surgery is invasive and often has significant side effects, including fluid retention, swelling and limited range of motion. In most cases -- 80 percent -- the test shows that the cancer hasn't spread. That is a relief to the patient. But both doctors and patients have long hoped for a way to learn these results without surgery.
Now Washington University professors are developing techniques using Bell's photoacoustic effect. The new imaging technology being developed by Lihong Wang and his colleagues will identify the sentinel lymph node (the first one to drain the breast) and guide the doctor in taking a needle biopsy. For most patients, that biopsy will reveal that the cancer has not spread and those underarm nodes can remain in place and keep working to drain the area.
What is the photoacoustic effect, and how does it translate to medical imaging?
We are dealing with the world of the very small. When the photon particles in a pulse of light hit a tissue sample, the sample heats up a tiny bit. The heating causes vibration (known as "thermoelastic expansion"), and the vibration gives off sound waves. If the pulse of light is strong enough, the sound waves can be picked up by ultrasound detectors. Then, just as you can locate a flash of lightening by timing thunderclaps, you can detect the source of the sound waves by triangulation.
Lasers at a low intensity that are safe for human use can excite tissue enough to create detectable ultrasound. Sound doesn't scatter very much, so as detectors map the echo, you are actually listening to the light.
Only seven years ago, Wang, a professor of biomedical engineering, published an article that began a revolution in medical imaging. He and his colleagues used photoacoustic imaging to show all sorts of things in a rat's brain, looking right through the skin and the skull.
As far as the laser's light energy could penetrate, the ultrasound image could show brain structures, the location of blood vessels and even localized responses to stimulation. Since then, research has exploded to the point where more scientific papers are published on photoacoustic imaging than any other type of optical imaging in biomedicine.
To show how photoacoustics can guide a needle to a sentinel lymph node, Wang and colleagues first gave a rat an injection of the dye methylene blue just under the skin.
Methylene blue, an FDA approved agent, will collect in the sentinel lymph node. Rats being quite small, the node will be quite close to the skin. To show that the laser stimulation will work in deeper human tissue, they overlaid the node area with a chunk of chicken breast about an inch thick and shone the light through that. Then they followed the needle as it approached the lymph node. Both the node and needle are clearly visualized, as contrasted to ultrasound alone.
As soon as the university gives approval, they will begin imaging patients. They are working with Philips to develop a combination ultrasound and photoacoustic machine.
Photoacoustic imaging is so sensitive that it can show a red blood cell moving through a capillary, as well as the complete vascular structure. It can show oxygenated blood in contrast to oxygen-depleted blood. This property is very useful for detecting tumors. Because tumors metabolize more rapidly than normal tissue, blood vessels emerging from them will have less oxygenated blood.
Nanoparticles can enhance imaging
But tiny tumors may not have a good blood supply, which makes them difficult to see with current imaging equipment.
Imaging is only the beginning of possible uses for the gold nanocage -- a box that will empty its contents when heated slightly by a low energy laser. It can be made to attach to particular cells by having a specific targeting agent such as an antibody bound to its surface. A nanocage could bind to a tumor and deliver a dose of an anticancer drug directly to the tumor.
The nanocage is a tiny box with all its corners missing. Each side is about 50 nanometers, or less than one-millionth of an inch. The polymer coating on the box seals and unseals the contents. At cool temperatures, the polymer forms a dense bushy tangle that effectively seals the corners. When the gold is heated, the polymer collapses and the corner holes are exposed.
A nanocage can be loaded with a drug in a warm solution that enters through the holes. When the nanocage is cooled, the polymer coat becomes bushy and the loaded drug is trapped inside. The drug will be released when gentle warming of the gold metal causes the polymer coat to contract and open the corners.
Enter another world of tiny things -- nanoparticles. Younan Xia, professor of biomedical engineering at Washington University, has developed hollow gold nanostructures that enhance the sensitivity of imaging. Gold is excellent at absorbing and scattering light, making it an ideal agent for optical imaging.
These tiny (30-60 nanometer) particles can be engineered to bind to certain proteins found only on the surface of cancer cells. As the particles bind, they enhance the optical properties of the tumors.
Xia and Wang are collaborating to make the visualization of sentinel lymph nodes more sensitive to photoaccoustic imaging by injecting gold nanoparticles within the layers of the skin.
As the gold particles collect in the node, they will absorb light very well, heat up and vibrate to give a strong ultrasound signal.
Different Imaging Technology using Nanoparticles
Yet another new type of imaging will use nanoparticles to help the patient avoid unnecessary procedures. This new technology, called spectral CT, can tell whether patients admitted to the emergency room for chest pain are actually having a heart attack.
"The vast majority of patients with chest pain do not have heart disease," said Dr. Gregory Lanza, associate professor of cardiology at Washington University School of Medicine. The pain may originate in the gut, in the chest muscle or elsewhere. Some heart attacks are easy to identify with an electrocardiogram. Others are not so obvious. To avoid the risk of sending a patient home who might have a later heart attack, many patients with chest pain are admitted to the hospital for extensive testing -- an expensive precaution.
A beating heart or pulsing artery needs the speed of CT analysis to obtain a clear picture.
A CT scan can tell whether coronary arteries have plaque build-up because plaque has calcium and the X-rays of the scan will show the calcium as white spots. But the blood clots that are the immediate cause of heart attacks do not show up on X-rays.
Spectral CT imaging shows both the artery and the clot. This newly developed technology uses nanoparticles that Lanza and colleagues construct to contain both a metal (such as gold or bismuth) and a molecule that will specifically bind to fibrin, the characteristic protein of a blood clot. Fibrin is never found in normal circulating blood; it is split off from a precursor only when a clot is formed.
As the nanoparticles bind to the clot, the metal particles are also bound. The spectral part of the spectral CT imager detects the metal and quantifies how much is bound. The clot will show as a colored image superimposed on the black and white image of the CT X-ray. The radiologist can then tell how big the clot is and whether it requires treatment.
Lanza believes that this technology and others on the drawing board will revolutionize cardiology. Wang predicts that photoacoustic imaging will have myriad applications, including detecting colon cancers that are below the surface scanned in a colonoscopy. Magnetic resonance imaging of the carotid artery with another type of nanoparticles developed in Lanza's lab may show physicians which of their patients are at great risk for stroke.
More powerful imaging techniques should help doctors tailor treatments to the needs of their individual patients.
Jo Seltzer is a freelance writer with more than 30 years on the research faculty at the Washington University School of Medicine and seven years teaching tech writing at WU's engineering school.
This article originally appeared in the St. Louis Beacon.